| Jason Noble, | |
|
2820 Mount Rushmore Rd, Rapid City, SD 57701-5462 | |
| (605) 342-3280 | |
| (605) 721-8458 |
| Full Name | Jason Noble |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 2820 Mount Rushmore Rd, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487853735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 8089 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rapid City Medical Center Llp | 5890691075 | 87 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.
Cardium Therapeutics (NYSE Amex: CXM) today announced a common stock private placement to selected investors for aggregate gross proceeds of $4.5 million.
Researchers from Beijing's National Institute of Biological Sciences, China have found a chemical in the brain controls sexual preference in mice. The study published in the journal Nature said that male mice bred without serotonin lose their preference for females. This is the first study that shows that a neurotransmitter plays a role in sexual preference in mammals. However it is still a long way before similar conclusions can be drawn for humans the experts believe.
Astellas Pharma Inc. announced today the completion of its tender offer for all outstanding shares of common stock in OSI Pharmaceuticals, Inc..
A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors' groups and cancer patients' advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women's groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.
› Verified 9 days ago
| Entity Name | Rapid City Medical Center Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558373845 PECOS PAC ID: 5890691075 Enrollment ID: O20031209000567 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.
Cardium Therapeutics (NYSE Amex: CXM) today announced a common stock private placement to selected investors for aggregate gross proceeds of $4.5 million.
Researchers from Beijing's National Institute of Biological Sciences, China have found a chemical in the brain controls sexual preference in mice. The study published in the journal Nature said that male mice bred without serotonin lose their preference for females. This is the first study that shows that a neurotransmitter plays a role in sexual preference in mammals. However it is still a long way before similar conclusions can be drawn for humans the experts believe.
Astellas Pharma Inc. announced today the completion of its tender offer for all outstanding shares of common stock in OSI Pharmaceuticals, Inc..
A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors' groups and cancer patients' advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women's groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Noble, Po Box 6020, Rapid City, SD 57709-6020 Ph: (605) 342-3280 | Jason Noble, 2820 Mount Rushmore Rd, Rapid City, SD 57701-5462 Ph: (605) 342-3280 |
News Archive
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.
Cardium Therapeutics (NYSE Amex: CXM) today announced a common stock private placement to selected investors for aggregate gross proceeds of $4.5 million.
Researchers from Beijing's National Institute of Biological Sciences, China have found a chemical in the brain controls sexual preference in mice. The study published in the journal Nature said that male mice bred without serotonin lose their preference for females. This is the first study that shows that a neurotransmitter plays a role in sexual preference in mammals. However it is still a long way before similar conclusions can be drawn for humans the experts believe.
Astellas Pharma Inc. announced today the completion of its tender offer for all outstanding shares of common stock in OSI Pharmaceuticals, Inc..
A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors' groups and cancer patients' advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women's groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.
› Verified 9 days ago
Tamara Poling, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 | |
Dr. Heather Rae Peck, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2805 5th St Ste 210, Rapid City, SD 57701 Phone: 605-343-2267 | |
Dr. Linda Jo Fromm, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4447 S Canyon Rd Ste 6, Rapid City, SD 57702 Phone: 605-721-5550 Fax: 605-721-5515 | |
Dr. Marc E Boddicker, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 710 Saint Anne St, Rapid City, SD 57701 Phone: 605-343-8000 Fax: 605-341-8575 | |
Cynthia A Anderson, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-721-8354 Fax: 605-721-8458 | |
Briana Hill, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 | |
Victoria Finley, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 |